MilevaNiya Profile Banner
Niya Mileva Profile
Niya Mileva

@MilevaNiya

Followers
1K
Following
1K
Statuses
447

MD, PhD, FESC, Cardiologist, CV imaging specialist, 🫀 Medical University, Sofia, 🇧🇬 Former Imaging and Research Fellow Cardiovascular Center OLV, Aalst, 🇧🇪

Joined January 2021
Don't wanna be here? Send us removal request.
@MilevaNiya
Niya Mileva
1 month
RT @danilorenzatti: A nice reminder that #HCM is not only about the thickened myocardium🥩. 🔎Always look for PM anomalies 😍 #cardiotwitter #…
0
23
0
@MilevaNiya
Niya Mileva
2 months
First data on aortic elastic properties evaluated by CTA and its relation with antihypertensive therapy. 🎯RAS(+)group had⬆️aortic distensibility and a preserved distensibility gradient compared to the RAS(−) group. Read more on @IJC_Heart_Vasc
Tweet media one
0
1
3
@MilevaNiya
Niya Mileva
2 months
RT @HEARTinMagnet: STATE-OF-THE-ART REVIEW IN @ehj_ed 🫀#whycmr in Mitral Valve Disease.🫀 Training videos included! 📽️
0
65
0
@MilevaNiya
Niya Mileva
3 months
RT @ThomPilgrim: Fibrotic versus calcific aortic stenosis in patients undergoing TAVR. @AMaznyczka @DomAngellotti @…
0
22
0
@MilevaNiya
Niya Mileva
3 months
RT @alex1708ander: #echofirst #CardioTwitter Intraop TEE in 4 patients with AR Type I: 🔘I A 🔘I B 🔘I C 🔘I D Repair-oriented classificati…
0
78
0
@MilevaNiya
Niya Mileva
3 months
RT @iamritu: 🆕📝optimal cutoff points for severe AS vary by range of LVEF (<35%, 35%-50%, >50%) 🫀If LVEF <35%, use M…
0
87
0
@MilevaNiya
Niya Mileva
3 months
RT @EHJIMPEiC: It’s a final countdown - tune in on @X space at 4 pm CET tomorrow & listen on how to interpret VHD LBCTs into clinical pract…
0
15
0
@MilevaNiya
Niya Mileva
3 months
📊Have you had a chance to take a look at the poll of the #EACVI Women in CV Imaging TF? Your voice is important! Expect a new question every two weeks. @JGrapsa @SHS06
Tweet media one
0
1
3
@MilevaNiya
Niya Mileva
4 months
RT @alex1708ander: #echofirst #CardioTwitter Intraop #3DTEE in a middle aged male with fever & fatigue, undergoing mitral valve surgery.…
0
20
0
@MilevaNiya
Niya Mileva
5 months
RT @alex1708ander: @AniHumanez99 @DrECMO Please don’t take offense. I just share my bad experience. Two examples (shown in TEE) where you…
0
3
0
@MilevaNiya
Niya Mileva
5 months
RT @ESC_Journals: What did you observe in the CT scan findings? A) A myxoma in the left atrium B) A giant atrial septal cardiac blood cy…
0
12
0
@MilevaNiya
Niya Mileva
5 months
RT @ecocardio_cl: Carcinoid heart disease by #WhyCMR #CardioTwitter
0
23
0
@MilevaNiya
Niya Mileva
5 months
RT @journalCCT: Latest SCCT guidelines are out, providing much needed expert consensus on definitions and standards for performance and rep…
0
16
0
@MilevaNiya
Niya Mileva
5 months
RT @ESC_Journals: Micro-nanoplastics and cardiovascular diseases: evidence and perspectives. A State-of-the-Art Review just published in #E
0
33
0
@MilevaNiya
Niya Mileva
5 months
RT @alex1708ander: #echofirst #CardioTwitter #CHD @JasaityteRuta LSVC (left persistent superior vena cava) 🔄 dilated coronary sinus (CS)…
0
20
0
@MilevaNiya
Niya Mileva
5 months
RT @Hragy: Novel therapy for ischaemia with no obstructive coronary arteries | European Heart Journal | Oxford Academic ⁦@InocaInternati1⁩…
0
7
0
@MilevaNiya
Niya Mileva
5 months
RT @jpcostabel: Paciente de 70 años con embolias en miembros inferiores y FA de larga data. Cuál es su sospecha con esta imagen? �� https://…
0
29
0
@MilevaNiya
Niya Mileva
5 months
RT @ACCinTouch: From ACC Vice President @ChrisKramerMD at #ESCCongress: CMR in #myocarditis: when should a genetic #cardiomyopathy be suspe…
0
17
0
@MilevaNiya
Niya Mileva
5 months
RT @mvaduganathan: 🔥 A new therapeutic era in #HFpEF #FINEARTSHF with definitive evidence supporting the role of the non-steroidal MRA fin…
0
185
0